Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4474 oral dosing in healthy volunteers and osteoarthritis patients
jRCT2080223824Phase 2
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ONO-4474 in osteoarthritis (OA) (3 arms), sponsored by Ono Pharmaceutical.
02
Drugs
ONO-4474
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2080223824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223824.